VXX News 29.09 09/15/2014 10:19:13 VIX Short-Term Futures ETN

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 29.09 $VXX

SmarTrend Watching for Potential Pullback in Shares of iPATH S&P 500 VIX Short-Term Futures ETN After 2.62% Gain
Comtex SmarTrend(R) - Tue Sep 09, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.64 to a high of $28.43. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $28.34 on volume of 29.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Pullback After Yesterday's Rally of 2.62%
Comtex SmarTrend(R) - Tue Sep 09, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.64 to a high of $28.43. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $28.34 on volume of 29.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 1.17% Sell Off
Comtex SmarTrend(R) - Wed Sep 03, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.82 to a high of $28.30. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $27.90 on volume of 22.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 1.17%
Comtex SmarTrend(R) - Wed Sep 03, 3:40PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.82 to a high of $28.30. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $27.90 on volume of 22.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

S&P 2,250 Closer Than You Think - Real Time Insight
Kevin Cook - ZACKS - Wed Aug 27, 11:37AM CDT
Why the market could add over 10% before it corrects 10%

SmarTrend Watching for Potential Rebound in Shares of iPATH S&P 500 VIX Short-Term Futures ETN After 1.08% Loss
Comtex SmarTrend(R) - Mon Aug 25, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.24 to a high of $27.64. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $27.53 on volume of 21.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 1.08% Yesterday
Comtex SmarTrend(R) - Mon Aug 25, 3:40PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.24 to a high of $27.64. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $27.53 on volume of 21.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

3 ETFs in Focus on Escalating Russia/Ukraine Tensions - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Aug 25, 1:00PM CDT
These ETFs look to be in focus for the coming days, especially in the wake of escalating Russia-Ukraine tensions.

The Yen May Be the Best Indicator at Deciphering Yellen's Tone
at The Street - Fri Aug 22, 10:47AM CDT
The yen has been been an accurate indicator of how investors perceive risk.

Last Week's ETF Highlights: MLP and Biotech Funds Soar, Volatility Sinks - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 20, 7:00AM CDT
Which ETFs led the market higher and lower last week?

After Yesterday's Decline of 1.08%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Tue Aug 19, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $27.38 to a high of $27.71. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $27.80 on volume of 24.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

S&P 500 Headed to 200-Day MA? - Real Time Insight
Kevin Cook - ZACKS - Tue Aug 12, 9:48AM CDT
The bounce is muted so far, but it sounds like sellers waiting in the wings

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 4.10% Yesterday
Comtex SmarTrend(R) - Mon Aug 11, 3:43PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $31.02 to a high of $32.71. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $32.55 on volume of 36.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 4.10%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Aug 11, 3:42PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $31.02 to a high of $32.71. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $32.55 on volume of 36.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Pullback in Shares of iPATH S&P 500 VIX Short-Term Futures ETN After 7.10% Gain
Comtex SmarTrend(R) - Tue Aug 05, 3:37PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $31.82 to a high of $34.28. Yesterday, the shares gained 7.1%, which took the trading range above the 3-day high of $33.73 on volume of 78.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Pullback After Gaining 7.10% Yesterday
Comtex SmarTrend(R) - Tue Aug 05, 3:36PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $31.82 to a high of $34.28. Yesterday, the shares gained 7.1%, which took the trading range above the 3-day high of $33.73 on volume of 78.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 249

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 231

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 432

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 211

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 367

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

Elanco Secures FDA EUA for Credelio in Fighting NWS in Dogs

Updated Category News Views 275

Elanco's Innovative Step Against New World Screwworm Elanco Animal Health Incorporated (NYSE: ELAN) has achieved a significant milestone, receiving the first Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its product, Credelio™ (lotilaner), designed to treat infestations of New World Screwworm (NWS) in dogs. This groundbreaking...

Continue Reading
Hillary Ashton Sells Teradata Shares: Insights and Implications

Updated Category News Views 412

Hillary Ashton’s Sale of Teradata Shares: A Closer Look In an important insider transaction, Hillary Ashton, who is the Chief Product Officer at Teradata (TDC), recently sold 14,962 shares of the company's stock. This sale brought in a total of $411,903, as revealed in a recent SEC filing that highlights insider activity within the company. Currently, Teradata's stock...

Continue Reading
Legal Updates for Investors of Humana Inc. Amid Lawsuit

Updated Category News Views 158

Understanding the Ongoing Lawsuit Against Humana Inc. Investors focusing on the recent activities surrounding Humana Inc. (NYSE: HUM) should be aware of a significant lawsuit that has implications for individuals who acquired shares prior to July 2022. The Shareholders Foundation, Inc. has provided updates concerning the ongoing legal proceedings relevant to these...

Continue Reading
Empowering Local Job Seekers: The Trimborns of AtWork Tampa

Updated Category News Views 231

AtWork Opens New Storefront in Tampa, Florida AtWork, a prominent staffing franchise known for empowering job seekers and fostering company growth, has expanded its presence with a new location in Tampa. This strategic establishment at 8402 Laurel Fair Circle, Suite 101, stands across the Florida State Fairgrounds, ready to cater to the needs of the local workforce. Meet...

Continue Reading
Investor Claims Wall Street is Collapsing Cryptocurrency Values

Updated Category News Views 227

Investor Claims Wall Street is Collapsing Cryptocurrency Values Mike Alfred, a noted investor and proponent of Bitcoin, has raised significant concerns regarding potential manipulation of the cryptocurrency markets by major Wall Street players. He believes that these entities are actively working to drive down Bitcoin prices specifically to pressure companies like...

Continue Reading